A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
- PMID: 7545954
- DOI: 10.1126/science.7545954
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
Abstract
A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and ovarian cancer, has been identified by positional cloning methods. Probable predisposing mutations have been detected in five of eight kindreds presumed to segregate BRCA1 susceptibility alleles. The mutations include an 11-base pair deletion, a 1-base pair insertion, a stop codon, a missense substitution, and an inferred regulatory mutation. The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids. This protein contains a zinc finger domain in its amino-terminal region, but is otherwise unrelated to previously described proteins. Identification of BRCA1 should facilitate early diagnosis of breast and ovarian cancer susceptibility in some individuals as well as a better understanding of breast cancer biology.
Similar articles
-
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.Am J Hum Genet. 1996 Mar;58(3):441-50. Am J Hum Genet. 1996. PMID: 8644702 Free PMC article.
-
BRCA1 mutations in primary breast and ovarian carcinomas.Science. 1994 Oct 7;266(5182):120-2. doi: 10.1126/science.7939630. Science. 1994. PMID: 7939630
-
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.Am J Hum Genet. 1996 Jan;58(1):42-51. Am J Hum Genet. 1996. PMID: 8554067 Free PMC article.
-
Has the breast cancer gene been found?Cell. 1994 Oct 7;79(1):1-3. doi: 10.1016/0092-8674(94)90393-x. Cell. 1994. PMID: 7923368 Review. No abstract available.
-
BRCA1 and prostate cancer.Cancer Invest. 2001;19(4):396-412. doi: 10.1081/cnv-100103134. Cancer Invest. 2001. PMID: 11405179 Review.
Cited by
-
Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic.Breast Cancer Res Treat. 2015 Apr;150(2):289-98. doi: 10.1007/s10549-015-3313-7. Epub 2015 Feb 28. Breast Cancer Res Treat. 2015. PMID: 25724305 Free PMC article.
-
Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies.Mol Ther Oncolytics. 2022 Aug 5;26:347-359. doi: 10.1016/j.omto.2022.08.005. eCollection 2022 Sep 15. Mol Ther Oncolytics. 2022. PMID: 36090475 Free PMC article. Review.
-
BRCA1/2 Mutations and Breast/Ovarian Cancer Risk: A New Insights Review.Reprod Sci. 2024 Dec;31(12):3624-3634. doi: 10.1007/s43032-024-01666-w. Epub 2024 Aug 6. Reprod Sci. 2024. PMID: 39107554 Review.
-
Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon.Hered Cancer Clin Pract. 2012 Jun 19;10(1):7. doi: 10.1186/1897-4287-10-7. Hered Cancer Clin Pract. 2012. PMID: 22713736 Free PMC article.
-
Similarities in the Age-Specific Incidence of Colon and Testicular Cancers.PLoS One. 2013 Jun 26;8(6):e66694. doi: 10.1371/journal.pone.0066694. Print 2013. PLoS One. 2013. PMID: 23840520 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous